IMC Chicago
ABCL icon

IMC Chicago’s AbCellera Biologics ABCL Stock Holding History

IMC Chicago’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.21M Buy
154,400
+10,000
+7% +$48.9K ﹤0.01% 3619
2026
Q1 		$504K Buy
144,400
+49,400
+52% +$178K ﹤0.01% 4037
2025
Q4 		$325K Buy
95,000
+47,400
+100% +$212K ﹤0.01% 3751
2025
Q3 		$239K Buy
+47,600
New +$210K ﹤0.01% 3494

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return

IMC Chicago's ABCL Position: Q2 2026 in Review

IMC Chicago opened a new position in AbCellera Biologics (ABCL) in Q2 2026: 17,205 shares worth $135K. The stake represents ﹤0.01% of the portfolio and ranks #5878 among its holdings. This is a return to the name: IMC Chicago previously reported a position in ABCL as recently as Q3 2025.

IMC Chicago first reported a position in ABCL in Q3 2025 and has held it in 2 quarters since. The position peaked at $468K in Q3 2025. 151 funds tracked by Wall St. Rank hold ABCL as of Q2 2026.

  • IMC Chicago held 17,205 shares of AbCellera Biologics worth $135K as of Q2 2026.
  • AbCellera Biologics was a new IMC Chicago position in Q2 2026.
  • AbCellera Biologics made up ﹤0.01% of IMC Chicago's portfolio in Q2 2026, its #5878 holding.
  • IMC Chicago first reported a position in AbCellera Biologics in Q3 2025 and has held it in 2 quarters since.
  • IMC Chicago's AbCellera Biologics position peaked at $468K in Q3 2025.
  • 151 funds tracked by Wall St. Rank held AbCellera Biologics as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.